Riskpilot← Back to searchSign inGet full accessAADALBIOTECH ApS
APSActiveCVR 31759668Harhoffs Alle 38Research and experimental development on natural sciences and engineering · NACE 7210Est. 20081 employees
Revenue 2024
DKK 105K
+23% vs 2023
EBITDA margin
100.0%
+42% vs 2023
Equity ratio
56.6%
Financial strength
Net profit 2024
DKK 35K
-54% vs 2023
| Revenue | DKK 105K | +23% |
| EBITDA | DKK 105K | +42% |
| Net profit | DKK 35K | -54% |
| Total assets | DKK 140K | +38% |
| Equity | DKK 79K | +81% |
| Employees | 1 | — |
Legal name
AADALBIOTECH ApS
CVR number
31759668
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
17. september 2008
Share capital
DKK 125.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er at drive investeringsvirksomhed
Address
Harhoffs Alle 38
Phone
+4561905064
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 35 | 29 | 1 | 218 | -54 | -8 | — | — | 17 | 20 | 0 | 85 | 105 |
| Staff expenses | -5 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 30 | 29 | 1 | 218 | -54 | -8 | -13 | -7 | 10 | 11 | -14 | 74 | 105 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 30 | 29 | 1 | 218 | -54 | -8 | -13 | -7 | 10 | 11 | -14 | 74 | 105 |
| Net financials | 101 | -0 | -3 | -1 | -3 | -32 | -2 | -7 | -40 | 65 | -38 | 4 | -46 |
| Profit before tax | -71 | 29 | -2 | 217 | -58 | -39 | -15 | -14 | -30 | 76 | -52 | 78 | 59 |
| Tax | 11 | 7 | -0 | 51 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 1 | 24 |
| Net profit | -81 | 22 | -2 | 166 | -58 | -39 | -15 | -14 | -30 | 76 | -52 | 77 | 35 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 6 | 2 | 55 | 190 | 112 | 10 | 12 | 70 | 47 | 122 | 68 | 101 | 140 |
| Equity | -87 | -66 | -68 | 98 | 40 | 1 | -14 | -28 | -58 | 18 | -33 | 44 | 79 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 94 | 68 | 123 | 92 | 71 | 9 | 26 | 99 | 106 | 103 | 101 | 58 | 61 |
| Total debt | 94 | 68 | 123 | 92 | 71 | 9 | 26 | 99 | 106 | 103 | 101 | 58 | 61 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20122024
Equity ratio
56.6%
This company
38.2%
Market median
+48% vs market
20122024
Return on equity
44.8%
This company
18.4%
Market median
+143% vs market
20122024
Net profit margin
33.8%
This company
8.1%
Market median
+317% vs market
20122024
Asset turnover
0.75×
This company
1.12×
Market median
-33% vs market
20122024
Debt / equity
0.77×
This company
0.62×
Market median
+24% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
VI Founder | Founder | 2008 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 66.7% | 66.7% | 2019 | |
| Individual | 20.0% | 20.0% | 2019 | |
| Individual | 10.0% | 10.0% | 2011 | |
| Individual | 15.0% | 15.0% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AADALBIOTECH ApS 
Tissue-Link ApSBoard members of AADALBIOTECH ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Verner Ingolf Aadal Nielsen | Founder | 0 companies |